Abstract | OBJECTIVE: The Prostate Carcinoma Tumor Antigen-1 (PCTA-1) is located at the prostate cancer susceptibility locus on chromosome 1q42.2-43 ( PCaP). In this candidate gene approach, we searched for deleterious mutations within the PCTA-1 gene and its promoter. MATERIALS AND METHODS: Seventy-seven familial prostate cancer cases from 36 German and French pedigrees were screened for germline mutations in the PCTA-1 gene using enzymatic mutation detection (EMD). Putative missense mutations were genotyped by RPLP and ddNTP primer extension assays in 88 controls to assess allele frequencies and haplotypes. RESULTS: Several sequence variants were found but none of the findings indicated a deleterious mutation. Three affected brothers showed an intronic variation, which may interfere with correct splicing. Four non-conservative SNPs were characterized, coding for the amino acid alterations Y19F, C36R, V56M and S184R. All exchanges were found in controls with common allelic frequencies of at least 28%. Haplotype definition including six SNPs within the PCTA-1 gene revealed a complete linkage disequilibrium. Low haplotype diversity leads to a predominance of only two peptide variants of the PCTA-1 protein, coded by 95% of all chromosomes. CONCLUSIONS: PCTA-1 is not a classical high risk gene with deleterious mutations predisposing to hereditary prostate cancer. Its contribution to prostate cancer susceptibility as a low risk factor in sporadic disease has to be assessed in larger samples by association studies.
|
Authors | C Maier, K Rösch, K Herkommer, S Bochum, G Cancel-Tassin, O Cussenot, J Häussler, G Assum, W Vogel, T Paiss |
Journal | European urology
(Eur Urol)
Vol. 42
Issue 3
Pg. 301-7
(Sep 2002)
ISSN: 0302-2838 [Print] Switzerland |
PMID | 12234517
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Galectins
- LGALS8 protein, human
|
Topics |
- Galectins
(genetics)
- Gene Frequency
(genetics)
- Genetic Predisposition to Disease
(genetics)
- Genotype
- Germ-Line Mutation
(genetics)
- Humans
- Male
- Pedigree
- Prostatic Neoplasms
(genetics)
- Risk Factors
|